NZ745950A - Methods and compositions for treating multiple sclerosis and related disorders - Google Patents

Methods and compositions for treating multiple sclerosis and related disorders

Info

Publication number
NZ745950A
NZ745950A NZ745950A NZ74595013A NZ745950A NZ 745950 A NZ745950 A NZ 745950A NZ 745950 A NZ745950 A NZ 745950A NZ 74595013 A NZ74595013 A NZ 74595013A NZ 745950 A NZ745950 A NZ 745950A
Authority
NZ
New Zealand
Prior art keywords
multiple sclerosis
methods
compositions
treating multiple
related disorders
Prior art date
Application number
NZ745950A
Inventor
Pedro Santamaria
Original Assignee
Uti Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/830,521 external-priority patent/US20140105980A1/en
Application filed by Uti Lp filed Critical Uti Lp
Publication of NZ745950A publication Critical patent/NZ745950A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This disclosure provides therapeutic compositions and methods for treating multiple sclerosis or a multiple sclerosis-related disorder in a subject in need thereof comprising administering an effective amount of an antigen-MHC-nanoparticle complex to the subject, wherein the antigen is a multiple sclerosis-related antigen.
NZ745950A 2012-10-11 2013-10-11 Methods and compositions for treating multiple sclerosis and related disorders NZ745950A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261712733P 2012-10-11 2012-10-11
US13/830,521 US20140105980A1 (en) 2012-10-11 2013-03-14 Methods and compositions for treating multiple sclerosis and related disorders
NZ70697013 2013-10-11

Publications (1)

Publication Number Publication Date
NZ745950A true NZ745950A (en) 2020-08-28

Family

ID=72265392

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ745950A NZ745950A (en) 2012-10-11 2013-10-11 Methods and compositions for treating multiple sclerosis and related disorders

Country Status (1)

Country Link
NZ (1) NZ745950A (en)

Similar Documents

Publication Publication Date Title
MX2019001977A (en) Methods and compositions for treating multiple sclerosis and related disorders.
MX2020010535A (en) Methods of treating cancer.
NZ707086A (en) Anti-cd40 antibodies and methods of use
PH12015502075A1 (en) Treatment of cataplexy
SG194701A1 (en) Anti-cd40 antibodies and methods of use
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
MX365835B (en) Use of akkermansia for treating metabolic disorders.
MX367341B (en) TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE.
TN2014000206A1 (en) Antibody molecules having specificity for human ox40
MX2016002645A (en) Combination therapy for the treatment of glioblastoma.
MX2015002669A (en) Methods of administering pirfenidone therapy.
IN2015DN00450A (en)
MX360189B (en) Combination therapy for the treatment of glioblastoma.
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
MX2014001766A (en) Neuregulin antibodies and uses thereof.
MY191932A (en) Chitosan-derived compositions
MX2016000220A (en) Regulation of glucose metabolism using anti-cgrp antibodies.
MX2015010296A (en) Treatment of multiple sclerosis with laquinimod.
MX356317B (en) Treatment of symptoms associated with female gastroparesis.
MX2016003293A (en) Methods and compositions for treatment of chlamydial infection and related diseases and disorders.
MX2016002307A (en) Cancer treatment.
EA201491522A1 (en) METHODS OF TREATING DISORDERS OF GAIT AND / OR BALANCE IN PATIENTS WITH MULTIPLE SCLEROSIS USING AMINOPYRIDINE
GB201115977D0 (en) Neurodevelopmental disorders
NZ745950A (en) Methods and compositions for treating multiple sclerosis and related disorders
IN2014DN07989A (en)

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2022 BY COMPUTER PACKAGES INC

Effective date: 20210917

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2023 BY COMPUTER PACKAGES INC

Effective date: 20220917

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2024 BY COMPUTER PACKAGES INC

Effective date: 20230917